The Patent Finder
AT

Avalo Therapeutics, Inc.

First filing 2016
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Cerecor, Inc. (to 2022)

6 patents currently held

4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2034. from the record

Of the 4 now held by other companies, 3 name Merck Sharp and Dohme LLC as their current owner, and 1 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2034
Next term end
4
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 25, 2027
    The maintenance fee for A Method of Treating Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury (ALI) Associated with COVID-19 by Administering an anti-LIGHT Antibody (US 11,708,406) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 6 of 6

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,245,396Inhalation Devices and Systems and Methods Including the Same
In force
 · Low confidence
In forceLow confidence
US 10,745,435Nucleic Acid Prodrugs
In force
 · High confidence
In forceHigh confidence
US 11,479,576Nucleic Acid Prodrugs
In force
 · High confidence
In forceHigh confidence
US 12,331,107Methods of Treating Pneumonia or Respiratory Failure Associated with COVID-19 by Administering an Anti-Light Antibody
In force
 · Low confidence
In forceLow confidence
US 11,708,406A Method of Treating Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury (ALI) Associated with COVID-19 by Administering an anti-LIGHT Antibody
In force
 · High confidence
In forceHigh confidence
US 12,799,190Method of Treating Conditions Associated with Elevated INTERLEUKIN-18 (IL-18) by Administering an ANTI-IL-18 Antibody
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 6: 4 patents in force now held by others · 6 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited